EUVIMEDEUVIMED entdecken
Crossref

Kidney fibrosis mechanisms in the single‑cell era: From cellular heterogeneity to therapeutic opportunities (Review)

Yinding Wang, Dong Yang, Na Liu, Hanyu Zeng

International Journal of Molecular Medicine · 17.11.2026 · 59 (1) · 1-21

DOI: 10.3892/ijmm.2026.6056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Medicine, online erschienen am 17.11.2026. Verfasst von Yinding Wang und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease affects >13% of adults worldwide, yet no approved antifibrotic therapy is available. Recent advances in single‑cell and spatial transcriptomics have transformed the understanding of renal fibrosis. These technologies have unmasked unexpected heterogeneity among myofibroblasts and macrophages, identified scar‑associated macrophage subsets and resolved the long‑standing debate over myofibroblast origins by confirming resident fibroblasts as the principal source. Spatial transcriptomics has further defined functional communities and pathologically distinct niches, including maladaptive repair niches centred on SOX9+ epithelial cells, profibrotic microenvironments enriched in tenascin‑C and immune‑activation niches where macrophages and fibroblasts co‑localize. Intercellular crosstalk networks involving TGF‑β, NOTCH and paracrine signals from injured tubules have been systematically mapped. These insights are now being translated into targeted strategies, such as surface marker‑directed agents against CD248 and fibroblast activation protein, epigenetic modulators including HDAC6 inhibitors and advanced 3D bioprinted human models. The present review synthesized these single‑cell and spatial discoveries to provide a conceptual framework for developing precision antifibrotic therapies for progressive kidney disease.

Zitieren

APA

Wang, Y., Yang, D., Liu, N., & Zeng, H. (2026). Kidney fibrosis mechanisms in the single‑cell era: From cellular heterogeneity to therapeutic opportunities (Review). International Journal of Molecular Medicine, 59(1), 1-21. https://doi.org/10.3892/ijmm.2026.6056

Vancouver

Wang Y, Yang D, Liu N, Zeng H. Kidney fibrosis mechanisms in the single‑cell era: From cellular heterogeneity to therapeutic opportunities (Review). International Journal of Molecular Medicine. 2026;59(1):1-21. doi:10.3892/ijmm.2026.6056

BibTeX
@article{Wang2026,
  author = {Wang, Yinding and Yang, Dong and Liu, Na and Zeng, Hanyu},
  title = {Kidney fibrosis mechanisms in the single‑cell era: From cellular heterogeneity to therapeutic opportunities (Review)},
  journal = {International Journal of Molecular Medicine},
  year = {2026},
  volume = {59},
  number = {1},
  pages = {1--21},
  doi = {10.3892/ijmm.2026.6056}
}
Kostenlos starten →